Every medication has side effects that can vary by individual, and GLP-1s are no exception
Longitudinal studies are needed to assess the durability of treatment response, evaluate the impact of Semaglutide on disease progression, and investigate potential benefits beyond glycemic control, such as cardiovascular protection, weight management, and preservation of renal function
The percentage of weight loss due to fat in the combination cohort was 92.8%, compared with 71.8% for semaglutide alone Semaglutide combined with bimagrumab preserved lean body mass, with only a 2.9% muscle loss compared to 7.4% for semaglutide when used alone
The rationale for the variation in diets between the groups lies in the nature of the intervention: the IF group focused on time-restricted eating, while the control group maintained a more conventional dietary pattern
Disruptions to treatment will slow down your weight loss progress and may have adverse effects
Take it in the exact dose and duration as prescribed by your doctor